DHEA as a miracle drug in the treatment of poor responders; Hype or hope?

Human Reproduction

Volumn 26, Issue 8, 2011, Pages 1941-1944

  Yakin, Kayhan ^a   Urman, Bulent ^a  

^a AMERICAN HOSPITAL   (Turkey)

Author keywords

assisted reproduction; counselling; dehydroepiandrosterone; ovarian reserve

Indexed keywords

GONADOTROPIN; PRASTERONE;

ACNE; AGING; ALOPECIA; DIMINISHED OVARY RESERVE; FERTILIZATION IN VITRO; GENETIC SCREENING; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; OVARIAN RESERVE; OVARY DISEASE; REVIEW; SIDE EFFECT; TREATMENT RESPONSE; VOICE CHANGE;

EID: 79960477689     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der150     Document Type: Review

References (31)

1. Arlt W. Dehydroepiandrosterone and aging. Best Pract Res Clin Endocrinol 2004;18:363.
2. Barad D, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005;84:756e1-3.
3. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocytes and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21:2845-2849. (Pubitemid 44566996)
4. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-634.
5. Borman E, Check JH, Wison C, Cohen R. No evidence to support the concept that low serum dehydroepiandrosterone (DHEA) sulphate (S) leves are associated with less oocytes production or lower pregnancy rates. Fertil Steril 2010;90(Suppl 1):S161.
6. Brill H, Barad D, Gleicher N. Dehydroepiandrosterone (DHEA) supplementation and pregnancy outcome: effect on pregnancy rate and speed of conception. Fertil Steril 2006;86(Suppl 2):S124.
7. Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129-2132.
8. Evers JHL. Publication bias in reproductive research. Hum Reprod 2000; 15:2063-2066.
9. Fleming TR. Clinical trials: discerning hype from substance. Ann Intern Med 2010;153:400-406.
10. Gleicher N, Barad D. Misplaced obsession with prospectively randomized studies. Reprod Biomed Online 2010;21:440-443.
11. Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol 2009;7:108-114.
12. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone (DHEA) supplementation. Reprod Biomed Online 2010a;21:360-365.
13. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010b;8:140-144.
14. Hyman EJ, Margalioth EJ, Rabinowitz R, Tsafrir A, Algur N, Eldar-Geva T. Dehydroepiandrosterone (DHEA) supplementation for poor responders-how does it work?. Fertil Steril 2010;94(Suppl):S86.
15. Karp G, Bentov Y, Masalha R, Ifergane G. Onset of late posttraumatic seizure after dehydtoepiadroserone treatment. Fertil Steril 2009; 91:931.e1-931.e2.
16. Kline MP, Jaggers ED. Mania onset while using dehydroepiandrosterone. Am J Psychiatry 1999;156:971.
17. Kolibianakis EM, Venetis CA, Tarlatzis BC. DHEA administration in poor responders. Hum Reprod 2011; doi:10.1093/humrep/deq397.
18. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 2008;5:e191: 13481356.
19. Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 2009a;91:644-646.
20. Mamas L, Mamas E. Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results. Curr Opin Obstet Gynecol 2009b; 21:306-308.
21. Markowitz JS, Carson WH, Jackson CW. Possible dihydroepiandrosterone- induced mania. Biol Psychiatry 1999;45:241.
22. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol 1998; 49:421-432. (Pubitemid 28475333)
23. Motta EL, Rossi LM, Fernandes TR, Massaguer AA, Foassolas G, Serafini P. The use DHEA in poor responders does not improve IVF outcomes: insights of a pilot study. Fertil Steril 2006;86(Suppl 2):S428.
24. Nakamura H, Nakasa H, Ishii I, Ariyoshi N, Igarashi T, Ohmori S, Kitada M. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab Dispos 2002;30:534.
25. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998; 280:1565. (Pubitemid 28520637)
26. Sadock BJ, Sadock VA (eds). Anabolic-androjenic steroid abuse. Kaplan & Sadock's Concise Textbook of Clinical Psychiatry, 3rd edn. Philadelphia, USA: Lippincott Williams & Wilkins, 2008, 151.
27. Sahelian R, Borken S. Dehydroepiandrosterone and cardiac arrhythmia. Ann Intern Med 1998;129:588.
28. Sonmezer M, Ozmen B, Cil AP, Ozkavukcu S, Tasci T, Olmus H, Atabekoglu CS. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reprod Biomed Online 2009;19:508-513.
29. Thompson RD, Carlson M, Thompson RD, Carlson M. Liquid chromatographic determination of dehydroepiandrosterone (DHEA) in dietary supplement products. J AOAC Int 2000;83:847.
30. Van Weering HGI, Gutknecht DR, Schats R. Augmentation of ovarian response by dehydroepiandrosterone.Hum Reprod 2001;16:1537-1538.
31. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 2010;25:2496-2500.